Results 301 to 310 of about 162,915 (338)
Some of the next articles are maybe not open access.

Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial

Journal of Clinical Oncology, 2021
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal radiation therapy (3D-CRT) in women ...
S. Chopra   +17 more
semanticscholar   +1 more source

Durability of the parotid‐sparing effect of intensity‐modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15‐year follow‐up of a randomized prospective study of IMRT versus two‐dimensional radiotherapy

Head and Neck, 2021
The durability of improved xerostomia with intensity‐modulated radiotherapy (IMRT) in patients with early stage nasopharyngeal carcinoma (NPC) is uncertain.
D. Poon   +5 more
semanticscholar   +1 more source

Intensity modulated radiotherapy

2012
Intensity-modulated radiotherapy (IMRT) is a radiation delivery technique that allows “dose sculpting” to improve target coverage while sparing normal tissues. In an IMRT plan, the number of photons delivered (or “fluence”) varies within a field. Such variability can be used to avoid normal structures with lower radiation tolerance than the cancer and ...
Bridget F. Koontz   +2 more
openaire   +2 more sources

Conformal Radiotherapy and Intensity-modulated Radiotherapy: Clinical Data

Acta Oncologica, 2000
Conformal radiotherapy (CRT) is based on three hypotheses: (i) a higher rate of local control can improve the survival rate; (ii) dose escalation can increase tumor control; and (iii) CRT allows the delivery of higher doses by decreasing the incidence of late effects. These postulates are now supported by several data.
M, Tubiana, F, Eschwège
openaire   +2 more sources

Submandibular Gland-sparing Intensity-modulated Radiotherapy

American Journal of Clinical Oncology, 2014
Xerostomia is one of the most debilitating late effects of head and neck radiotherapy (RT) and significantly impacts quality of life. The submandibular gland (SMG) provides approximately 70% of the unstimulated saliva that accounts for about 95% of the salivary flow during a 24-hour period. Intensity-modulated RT (IMRT) has been used in recent years to
William M, Mendenhall   +2 more
openaire   +2 more sources

Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics, 2012
To report the outcomes and toxicities in patients treated with intensity-modulated radiotherapy (IMRT) for pancreatic adenocarcinoma.Forty-seven patients with pancreatic adenocarcinoma were treated with IMRT between 2003 and 2008. Of these 47 patients, 29 were treated adjuvantly and 18 definitively.
Jonathan A, Abelson   +11 more
openaire   +2 more sources

Practical experience with intensity-modulated radiotherapy

The British Journal of Radiology, 2004
At the Ipswich Hospital implementation of intensity-modulated radiotherapy (IMRT) commenced in February 2001 based on an established 3D conformal radiotherapy (3D CRT) service. This paper describes our experiences as we commissioned a fully-integrated IMRT planning and delivery system, and established IMRT within the department.
H V, James, C D, Scrase, A J, Poynter
openaire   +2 more sources

Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma

Journal of Huazhong University of Science and Technology [Medical Sciences], 2011
Surgical excision and postoperative radiotherapy are widely accepted therapeutic modalities for sinonasal teratocarcinosarcoma (SNTCS). Previous studies have shown that intensity-modulated radiation therapy (IMRT) is safe and effective for the treatment of some sinonasal malignancies.
Gang, Peng   +5 more
openaire   +2 more sources

Rectal Radiotherapy — Intensity-modulated Radiotherapy Delivery, Delineation and Doses

Clinical Oncology, 2016
The use of intensity-modulated radiotherapy in rectal cancer is attractive in that it may reduce acute and late toxicities and potentially facilitate dose escalation. Intensity-modulated radiotherapy probably has a role in selected patients, but further investigation is required to identify the parameters for selection.
S, Teoh, R, Muirhead
openaire   +2 more sources

Home - About - Disclaimer - Privacy